1. BACH2 represses effector programmes to stabilize Treg-mediated immune homeostasis - a new target in tumor immunotherapy?. (7th November 2013) Authors: Roychoudhuri, Rahul; Hirahara, Kiyoshi; Mousavi, Kambiz; Clever, David; Bonelli, Michael; Klebanoff, Christopher; Sartorelli, Vittorio; Kanno, Yuka; Gattinoni, Luca; Wang, Ena; Liu, Hui; Marincola, Franco; Kazuhiko, Igarashi; O'Shea, John; Restifo, Nicholas P Journal: Journal for immunotherapy of cancer Issue: Volume 1(2013)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CCR8 marks highly suppressive Treg cells within tumours but is dispensable for their accumulation and suppressive function. Issue 4 (9th May 2021) Authors: Whiteside, Sarah K.; Grant, Francis M.; Gyori, David S.; Conti, Alberto G.; Imianowski, Charlotte J.; Kuo, Paula; Nasrallah, Rabab; Sadiyah, Firas; Lira, Sergio A.; Tacke, Frank; Eil, Robert L.; Burton, Oliver T.; Dooley, James; Liston, Adrian; Okkenhaug, Klaus; Yang, Jie; Roychoudhuri, Rahul Journal: Immunology Issue: Volume 163:Issue 4(2021) Page Start: 512 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cish actively silences tcr signaling in CD8+ T cells to maintain tumor tolerance. (4th November 2015) Authors: Palmer, Douglas; Guittard, Geoff; Franco, Zulmarie; Patel, Shashank; Klebanoff, Christopher A; Sukumar, Madhusudhanan; Eil, Robert L; Clever, David; Balagopalan, Lakshmi; Roychoudhuri, Rahul; Samelson, Larry; Restifo, Nicholas Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cish actively silences tcr signaling in CD8+ T cells to maintain tumor tolerance. Issue 2 (December 2015) Authors: Palmer, Douglas; Guittard, Geoff; Franco, Zulmarie; Patel, Shashank; Klebanoff, Christopher; Sukumar, Madhusudhanan; Eil, Robert; Clever, David; Balagopalan, Lakshmi; Roychoudhuri, Rahul; Samelson, Larry; Restifo, Nicholas Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Elevated potassium levels suppress T cell activation within tumors. (4th November 2015) Authors: Eil, Robert L; Roychoudhuri, Rahul; Clever, David; Patel, Shashank; Sukumar, Madhu; Pan, Jenny H; Palmer, Douglas; Klebanoff, Christopher A; Restifo, Nicholas P Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Elevated potassium levels suppress T cell activation within tumors. Issue 2 (December 2015) Authors: Eil, Robert; Roychoudhuri, Rahul; Clever, David; Patel, Shashank; Sukumar, Madhu; Pan, Jenny; Palmer, Douglas; Klebanoff, Christopher; Restifo, Nicholas Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Genome‐Wide Measurement and Computational Analysis of Transcription Factor Binding and Chromatin Accessibility in Lymphocytes. (19th July 2019) Authors: Sadiyah, M. Firas; Roychoudhuri, Rahul Editors: Coligan, John E.; Bierer, Barbara E.; Margulies, David H.; Shevach, Ethan M.; Strober, Warren Journal: Current protocols in immunology Issue: Volume 126(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Immunotherapy generates selective pressure for acquisition of immunogenic neoantigens in escape tumors. (4th November 2015) Authors: Pan, Jenny H; Vodnala, Suman; Eil, Robert L; Yu, Zhiya; Gartner, Jared J; Clever, David; Roychoudhuri, Rahul; Patel, Shashank J; Klebanoff, Christopher A; Sukumar, Madhusudhanan; Yamamoto, Tori; Restifo, Nicholas P Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Immunotherapy generates selective pressure for acquisition of immunogenic neoantigens in escape tumors. Issue 2 (December 2015) Authors: Pan, Jenny; Vodnala, Suman; Eil, Robert; Yu, Zhiya; Gartner, Jared; Clever, David; Roychoudhuri, Rahul; Patel, Shashank; Klebanoff, Christopher; Sukumar, Madhusudhanan; Yamamoto, Tori; Restifo, Nicholas Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Inhibition of the T cell oxygen sensing machinery promotes anti-tumor efficacy. (4th November 2015) Authors: Clever, David; Roychoudhuri, Rahul; Restifo, Nicholas P Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗